Federal prosecutors handling the government’s criminal case against Theranos founder Elizabeth Holmes have fired back at claims that they failed to allege any single fraudulent statement or misrepresentation made about the now-defunct blood-testing company.

In court papers filed Monday, prosecutors argued that they charged the wire fraud case against Holmes and her codefendant, former company president Ramesh Balwani, in a way that does not require them to prove any particular statement was false. But the prosecutors further pointed to nine separate representations Holmes and Balwani allegedly made to investors, patients and doctors about the reliability of Theranos’ blood tests and the company’s financial viability that they say proved to be false. Prosecutors wrote that the defense has already been provided with interview notes from investors who said Holmes had misled them to believe that Theranos’ analyzer could perform more than 100 tests using a finger prick and slide decks from presentations to investors that were “brimming with false statements.”